OK Science and Technology Co., Ltd. (SHE:001223)
China · Delayed Price · Currency is CNY 59.00
+0.82 (1.41%)
May 8, 2026, 3:04 PM CST
OK Science and Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 955.87 | 408.52 | 299.53 | 501.22 | 546.9 |
Other Revenue | - | 25.95 | 32.78 | 15.68 | 11.56 |
| 955.87 | 434.47 | 332.3 | 516.9 | 558.46 | |
Revenue Growth (YoY) | 120.01% | 30.75% | -35.71% | -7.44% | 5.61% |
Cost of Revenue | 699.36 | 302.78 | 228.9 | 275.12 | 293.25 |
Gross Profit | 256.51 | 131.69 | 103.4 | 241.78 | 265.21 |
Selling, General & Admin | 85.44 | 63.35 | 47.06 | 48.2 | 31.76 |
Research & Development | 30.08 | 34.05 | 23.23 | 22.2 | 25.55 |
Other Operating Expenses | -6.36 | 2.32 | -5.95 | -26.6 | -23.52 |
Operating Expenses | 109.17 | 137.74 | 87.81 | 58.8 | 34.74 |
Operating Income | 147.34 | -6.05 | 15.59 | 182.98 | 230.47 |
Interest Expense | - | -0.92 | -0.13 | -0.92 | -1.67 |
Interest & Investment Income | - | 8.61 | 24.81 | 2.64 | 0.89 |
Earnings From Equity Investments | -0.71 | 3.77 | - | - | - |
Currency Exchange Gain (Loss) | - | 1.53 | -0.26 | 2.9 | -1.35 |
Other Non Operating Income (Expenses) | -68.43 | 8.53 | -0.08 | -0.15 | -0.22 |
EBT Excluding Unusual Items | 78.21 | 15.49 | 39.93 | 187.43 | 228.12 |
Gain (Loss) on Sale of Investments | 1.68 | - | - | -0.21 | - |
Gain (Loss) on Sale of Assets | -0.56 | - | - | - | - |
Asset Writedown | -4.14 | -0.11 | - | - | - |
Other Unusual Items | - | 16.71 | 88.06 | 27.28 | 34.75 |
Pretax Income | 75.18 | 32.09 | 127.99 | 214.5 | 262.87 |
Income Tax Expense | 31.03 | -3.5 | 14.06 | 31.28 | 34.25 |
Earnings From Continuing Operations | 44.15 | 35.59 | 113.93 | 183.22 | 228.63 |
Minority Interest in Earnings | -3.29 | -1.3 | - | - | - |
Net Income | 40.86 | 34.29 | 113.93 | 183.22 | 228.63 |
Net Income to Common | 40.86 | 34.29 | 113.93 | 183.22 | 228.63 |
Net Income Growth | 19.16% | -69.91% | -37.82% | -19.86% | -7.32% |
Shares Outstanding (Basic) | 93 | 93 | 93 | 70 | 70 |
Shares Outstanding (Diluted) | 93 | 93 | 93 | 70 | 70 |
Shares Change (YoY) | -0.01% | -0.01% | 33.37% | - | -0.08% |
EPS (Basic) | 0.44 | 0.37 | 1.22 | 2.62 | 3.27 |
EPS (Diluted) | 0.44 | 0.37 | 1.22 | 2.62 | 3.27 |
EPS Growth | 19.17% | -69.90% | -53.37% | -19.86% | -7.25% |
Free Cash Flow | 87.2 | -173.52 | -317.18 | -4.45 | 40.57 |
Free Cash Flow Per Share | 0.93 | -1.86 | -3.40 | -0.06 | 0.58 |
Dividend Per Share | - | 0.107 | 0.571 | - | - |
Dividend Growth | - | -81.26% | - | - | - |
Gross Margin | 26.83% | 30.31% | 31.12% | 46.77% | 47.49% |
Operating Margin | 15.42% | -1.39% | 4.69% | 35.40% | 41.27% |
Profit Margin | 4.27% | 7.89% | 34.29% | 35.45% | 40.94% |
Free Cash Flow Margin | 9.12% | -39.94% | -95.45% | -0.86% | 7.26% |
EBITDA | 201.88 | 30.94 | 38.69 | 203.36 | 241.69 |
EBITDA Margin | 21.12% | 7.12% | 11.64% | 39.34% | 43.28% |
D&A For EBITDA | 54.54 | 36.99 | 23.1 | 20.39 | 11.22 |
EBIT | 147.34 | -6.05 | 15.59 | 182.98 | 230.47 |
EBIT Margin | 15.42% | -1.39% | 4.69% | 35.40% | 41.27% |
Effective Tax Rate | 41.27% | - | 10.98% | 14.58% | 13.03% |
Revenue as Reported | - | 434.47 | 332.3 | 516.9 | 558.46 |
Advertising Expenses | - | 4.12 | 3.86 | 4.14 | 0.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.